Oklo Inc. Class A common stock (OKLO)

Oklo (NYSE:OKLO) reported a year-to-date net loss of $81.6 million through the second quarter of 2026 while outlining progress across its power, fuel and isotope businesses, including first criticality at its Groves isotope facility in Texas and continued development of its Aurora powerhouse project

What does $12 billion of market value buy when combined sales run about $12 million?

Nuclear energy will be a multi-trillion-dollar opportunity.

Groves facility reaches first criticality in under 11 months.

Oklo achieved a crucial milestone.

Oklo Inc. (NYSE: OKLO) (“Oklo” or “the Company”), an advanced nuclear technology company, today published its financial results and business update for the second quarter ended June 30, 2026.

With virtually no revenue line to judge, four things decide this report.

High expectations leave little room for disappointment.

Nuclear investment is still growing, but nuclear share prices have been shrinking.

Supercharge your portfolio with this leading option for nuclear energy industry exposure.

Oklo Inc. (NYSE: OKLO) ("Oklo" or "the Company"), an advanced nuclear technology company, today announced that its Groves Isotope Test Reactor has achieved first criticality after achieving a controlled, self-sustaining nuclear chain reaction at low power. The milestone comes less than a year after groundbreaking and follows U.S. Department of Energy (DOE) authorization through the DOE Reactor Pilot Program (RPP).

A positive update on Oklo's reactor progress could reverse the nuclear stock's downward spiral.

Shares of Oklo have fallen close to 40% this year.

From Berkshire Hathaway to Oklo, there are plenty of ways to construct a diversified energy portfolio with $10,000.

Oklo could survive an AI bust, but its valuation probably couldn't.

One sells power today with $2B in revenue and major partnerships; the other has zero revenue but billion-dollar customer commitments.

Which of these three high-tech market newcomers is the best?

The Microsoft co-founder is betting billions on the future of nuclear power.

Bloom is making money in the here and now, while Oklo and NuScale are not.

There's a reason the hype around these two nuclear technology stocks is fading.

Nuclear power stocks are set to benefit from rising electricity demand.

Oklo has plunged from last year's highs, but its progress and leadership could make it a compelling buy.

One is pre-revenue with zero debt; the other generates $710 million in sales but burns cash faster.

Oklo remains a very risky way to play the nuclear power resurgence.